Other cardiovascular drugs × cardiovascular events

TrialThe New England journal of medicine2014

Ivabradine in stable coronary artery disease without clinical heart failure.

Kim Fox et al.PubMed ↗Publisher ↗

What the trial testedas reported · 19,102 people · 2014

Range includes no effect

No clear effect on cardiovascular events

+8%−4% to +20%

Bigger than 1 in 10 for cardiovascular events

As reported

HR 1.08, 95% CI 0.96–1.20

One number in the abstract

the abstract, start to end

and 6.4%, respectively; hazard ratio, 1.08; 95% confidence interval, 0.96

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
HR 1.080.96–1.20
Other cardiovascular drugsCardiovascular events

Other cardiovascular drugs × cardiovascular eventshelps?no deciding trial

unlikelylikely
0.25only evidence
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

156 papers cite itlatest 60 shown

2014
2015
2016
2017
2018
2020
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 25176136